ArticleNAR genomics and bioinformatics2025
EnhancerMatcher: comparing cell-type-specific enhancer activity of DNA sequences using deep convolutional neural networks and explainable AI.
Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Transcriptional enhancers-unlike promoters-are challenging to identify computationally due to their variable distance and orientation relative to target genes. The scarcity of experimentally confirmed enhancers often limits the training of robust machine-learning models for enhancer prediction. We present EnhancerMatcher, a convolutional neural network-based tool that identifies cell-type-specific enhancers using only two confirmed enhancers as references. Trained on putative enhancers from the CATlas Project and control sequences from the human genome, EnhancerMatcher classifies sequences in triplets: two known enhancers from a common cell type and a third sequence evaluated for enhancer activity. Unlike existing methods, EnhancerMatcher enables classification across all cell types while preserving specificity through two reference enhancers. It achieved 90% accuracy, 92% recall, and 87% specificity on human test data. Furthermore, EnhancerMatcher demonstrated strong cross-species generalization, effectively recognizing mouse enhancers using its human-trained model, and exhibited consistent performance across diverse cell types regardless of their data representation size. EnhancerMatcher extracts features directly from raw sequences and provides interpretability through class activation maps, making it a powerful, versatile, and generalizable tool for enhancer discovery and regulatory sequence analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.